|
Each week, IBM will highlight a story from around the world where IBM engineers are collaborating with clients, business partners, ISV's and education institutions to bring the latest technology to the market in new and innovative ways. |
Did you know...
...with its installation in July, the University of Canterbury will be the first research institution in the Southern Hemisphere to benefit from the IBM Blue Gene supercomputer, ranking it the most powerful system in New Zealand and among the elite U.S. research-led universities such as Harvard, Princeton and the Massachusetts Institute of Technology (MIT)?
Since Blue Gene's introduction in 1999, this energy-efficient supercomputer has been implemented across a variety of scientific disciplines, and included in an array of academic and research institutions. For the University of Canterbury, the Blue Gene technology will allow researchers to team with places like the Christchurch School of Medicine and The MacDiarmid Institute for Advanced Materials and Nanotechnology to address a number of clinical questions and scientific challenges.
Since Blue Gene's introduction in 1999, this energy-efficient supercomputer has been implemented across a variety of scientific disciplines, and included in an array of academic and research institutions. For the University of Canterbury, the Blue Gene technology will allow researchers to team with places like the Christchurch School of Medicine and The MacDiarmid Institute for Advanced Materials and Nanotechnology to address a number of clinical questions and scientific challenges.
IBM's relationship with the University of Canterbury has allowed both to delve deeper into areas of mutual research interests, allowing for endless human possibilities.
You can see the press release here.
See how IBM is collaborating with clients in unique ways in next Friday's installment of 40 Clients in 40 Weeks!
| 
